These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 17217540)
1. Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival. Fulford LG; Reis-Filho JS; Ryder K; Jones C; Gillett CE; Hanby A; Easton D; Lakhani SR Breast Cancer Res; 2007; 9(1):R4. PubMed ID: 17217540 [TBL] [Abstract][Full Text] [Related]
2. Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation. Rakha EA; Putti TC; Abd El-Rehim DM; Paish C; Green AR; Powe DG; Lee AH; Robertson JF; Ellis IO J Pathol; 2006 Mar; 208(4):495-506. PubMed ID: 16429394 [TBL] [Abstract][Full Text] [Related]
3. BRCA-mutated Invasive Breast Carcinomas: Immunohistochemical Analysis of Insulin-like Growth Factor II mRNA-binding Protein (IMP3), Cytokeratin 8/18, and Cytokeratin 14. Mohanty SK; Lai JP; Gordon OK; Pradhan D; Bose S; Dadmanesh F Breast J; 2015; 21(6):596-603. PubMed ID: 26390986 [TBL] [Abstract][Full Text] [Related]
4. [Clinicopathologic study of centrally necrotizing carcinoma of breast]. Yu L; Yang WT; Cai X; Lu HF; Fan YZ; Shi DR Zhonghua Bing Li Xue Za Zhi; 2009 Oct; 38(10):657-62. PubMed ID: 20078968 [TBL] [Abstract][Full Text] [Related]
5. Maspin expression is frequent and correlates with basal markers in triple-negative breast cancer. Umekita Y; Ohi Y; Souda M; Rai Y; Sagara Y; Sagara Y; Tamada S; Tanimoto A Diagn Pathol; 2011 Apr; 6():36. PubMed ID: 21496280 [TBL] [Abstract][Full Text] [Related]
6. [Roles of immunohistochemistry in prognostic assessment of basal-like breast cancer]. Liu H; Fan QH; Zhang ZH; Li X; Yu HP; Liu GZ; Meng FQ Zhonghua Bing Li Xue Za Zhi; 2009 Jan; 38(1):23-8. PubMed ID: 19489221 [TBL] [Abstract][Full Text] [Related]
7. Cytokeratin profiles of male breast cancers. Ciocca V; Bombonati A; Gatalica Z; Di Pasquale M; Milos A; Ruiz-Orrico A; Dreher D; Folch N; Monzon F; Santeusanio G; Perou CM; Bernard PS; Palazzo JP Histopathology; 2006 Oct; 49(4):365-70. PubMed ID: 16978199 [TBL] [Abstract][Full Text] [Related]
8. CGH analysis of ductal carcinoma of the breast with basaloid/myoepithelial cell differentiation. Jones C; Nonni AV; Fulford L; Merrett S; Chaggar R; Eusebi V; Lakhani SR Br J Cancer; 2001 Aug; 85(3):422-7. PubMed ID: 11487275 [TBL] [Abstract][Full Text] [Related]
9. [Basal and myoepithelial phenotype of metastatic mammary carcinomas. A prognostic factor in the palliative situation?]. Mainka P; Kahlert S; Kirchner T; Mayr D; Diebold J Pathologe; 2008 Nov; 29 Suppl 2():363-9. PubMed ID: 18807040 [TBL] [Abstract][Full Text] [Related]
10. Molecular cytogenetic identification of subgroups of grade III invasive ductal breast carcinomas with different clinical outcomes. Jones C; Ford E; Gillett C; Ryder K; Merrett S; Reis-Filho JS; Fulford LG; Hanby A; Lakhani SR Clin Cancer Res; 2004 Sep; 10(18 Pt 1):5988-97. PubMed ID: 15447982 [TBL] [Abstract][Full Text] [Related]
11. Cytokeratin 7 negative invasive breast carcinoma: clinicopathological and immunohistochemical analysis of 14 cases with clinical follow-up. Moatamed NA; Wu A; Sarah K; Apple SK J Clin Pathol; 2015 Jun; 68(6):484-7. PubMed ID: 25710705 [TBL] [Abstract][Full Text] [Related]
12. Characteristics of basal cytokeratin expression in breast cancer. Alshareeda AT; Soria D; Garibaldi JM; Rakha E; Nolan C; Ellis IO; Green AR Breast Cancer Res Treat; 2013 May; 139(1):23-37. PubMed ID: 23588953 [TBL] [Abstract][Full Text] [Related]
13. Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast. Fulford LG; Easton DF; Reis-Filho JS; Sofronis A; Gillett CE; Lakhani SR; Hanby A Histopathology; 2006 Jul; 49(1):22-34. PubMed ID: 16842243 [TBL] [Abstract][Full Text] [Related]
14. Basal markers and prognosis in luminal breast cancer. Engstrøm MJ; Valla M; Bofin AM Breast Cancer Res Treat; 2017 Jun; 163(2):207-217. PubMed ID: 28258354 [TBL] [Abstract][Full Text] [Related]
15. The cytokeratin profile of medullary carcinoma of the breast. Tot T Histopathology; 2000 Aug; 37(2):175-81. PubMed ID: 10931242 [TBL] [Abstract][Full Text] [Related]
16. Centrally necrotizing carcinoma of the breast: clinicopathological analysis of 33 cases indicating its basal-like phenotype and poor prognosis. Yu L; Yang W; Cai X; Shi D; Fan Y; Lu H Histopathology; 2010 Aug; 57(2):193-201. PubMed ID: 20716161 [TBL] [Abstract][Full Text] [Related]
17. [Basal-like breast cancers: clinicopathological features and outcome]. De Brot M; Soares FA; Stiepcich MM; Cúrcio VS; Gobbi H Rev Assoc Med Bras (1992); 2009; 55(5):529-34. PubMed ID: 19918651 [TBL] [Abstract][Full Text] [Related]
18. The influence of basal phenotype on the metastatic pattern of breast cancer. Luck AA; Evans AJ; Green AR; Rakha EA; Paish C; Ellis IO Clin Oncol (R Coll Radiol); 2008 Feb; 20(1):40-5. PubMed ID: 17981444 [TBL] [Abstract][Full Text] [Related]
19. Androgen receptor and FOXA1 coexpression define a "luminal-AR" subtype of feline mammary carcinomas, spontaneous models of breast cancer. Dagher E; Royer V; Buchet P; Abadie J; Loussouarn D; Campone M; Nguyen F BMC Cancer; 2019 Dec; 19(1):1267. PubMed ID: 31888566 [TBL] [Abstract][Full Text] [Related]
20. The proteins FABP7 and OATP2 are associated with the basal phenotype and patient outcome in human breast cancer. Zhang H; Rakha EA; Ball GR; Spiteri I; Aleskandarany M; Paish EC; Powe DG; Macmillan RD; Caldas C; Ellis IO; Green AR Breast Cancer Res Treat; 2010 May; 121(1):41-51. PubMed ID: 19590950 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]